Sulfamethoxypyridazine CAS: 80-35-3

CAS NO: 80-35-3
Sulfamethoxypyridazine
Chemical Name: Sulfamethoxypyridazine
Molecular Formula: C11H12N4O3S
Formula Weight: 280.3
CAS No.: 80-35-3
Description Review
Description

Sulfamethoxypyridazine is an antibacterial agent derived from the sulfonamide drug class. It was initially developed in Germany in the 1930s and later found to be effective in treating a variety of bacterial infections. The chemical name for Sulfamethoxypyridazine is 2-(Para-amino-benzenesulfonamido)-pyridazine, while its molecular formula is C11H12N4O3S and its formula weight is 284.3. Its CAS number is 80-35-3.

Top Ten Keywords from Google and Synonyms

  1. Sulfamethoxypyridazine uses
  2. Sulfamethoxypyridazine side effects
  3. Sulfamethoxypyridazine dosage
  4. Mafenide
  5. Sulfadiazine
  6. Sulfamethoxazole
  7. Sulfonamide
  8. Sulfadimidine
  9. Sulfachloropyridazine
  10. Sulfapyridine

Health Benefits of Sulfamethoxypyridazine

Sulfamethoxypyridazine is an antibacterial agent that is effective in treating several bacterial infections. It has been used to treat urinary tract infections, respiratory tract infections, and bacterial infections of the skin. It can also be used to treat bacterial meningitis and other severe bacterial infections.

Potential Effects of Sulfamethoxypyridazine

The potential effects of Sulfamethoxypyridazine are due to its ability to inhibit the production of folic acid in bacteria. This acid is required for the formation of DNA and other essential components of bacterial cell division, therefore inhibition of its production results in the termination of bacterial growth and cell death.

Product Mechanism

Sulfamethoxypyridazine works by inhibiting the production of folic acid in bacteria. Folic acid is an essential component required in the production of DNA, RNA, and protein synthesis. Sulfamethoxypyridazine has been found to compete with para-aminobenzoic acid (PABA), a precursor of folic acid, which leads to the inhibition of bacterial growth by preventing the production of folic acid.

Safety

Sulfamethoxypyridazine is generally considered to be safe for human use, but as with any medication, there may be some side effects, which might be severe in some cases. Before starting to use this product, it's essential to consult with a healthcare professional.

Side Effects

Sulfamethoxypyridazine may cause some side effects, including rash, itching, hives, fever, sore throat, unusual bleeding or bruising, yellowing of the skin or eyes, unusual tiredness, unusual weakness, mood changes, seizures, or depression.

Dosing Information

Sulfamethoxypyridazine is usually administered through oral routes. It's common to take this medication with food or milk to lessen stomach upset. The dosing information of Sulfamethoxypyridazine depends on the condition being treated, age, weight, and general health. Ensure you read the product label before beginning to use this medication, and do not exceed the prescribed dosage.

Conclusion

Sulfamethoxypyridazine is a potent antibacterial agent that has proven to be effective in treating a variety of bacterial infections. It's essential to consult with a healthcare professional before starting to use this medication, as it may have some side effects. Understanding the product mechanism of Sulfamethoxypyridazine is essential, as it helps one to understand how it works to treat bacterial infections. It's also important to follow the prescribed dosing information and not to exceed the recommended dosage. In conclusion, Sulfamethoxypyridazine is an excellent medication for bacterial infections that you can utilize to ensure you get better

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code